World's Best Scientists 2026 revealed!
Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Medicine

D-Index
128
Citations
68094
World Ranking
2687
National Ranking
35

Research.com Recognitions

  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Alois Gratwohl is a researcher affiliated with the University of Basel in Switzerland. Their work is primarily situated in the field of Medicine, with a notable focus on Hematology alongside contributions to Genetics, Rheumatology, Biomedical Engineering, and Public Health, Environmental and Occupational Health.

The scientific output of Alois Gratwohl includes research topics that cover hematopoietic stem cell transplantation, chronic lymphocytic leukemia, chronic myeloid leukemia treatments, eosinophilic disorders and syndromes, acute lymphoblastic leukemia, childhood cancer survivors' quality of life, and biomedical and engineering education.

Prominent recent publications authored or coauthored by Alois Gratwohl include:

  • High-risk additional chromosomal abnormalities at low blast counts herald death by CML, 2020, Leukemia
  • Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States, 2020, Cancer
  • Visions for a JACIE Quality Management System 4.0, 2021, Bone Marrow Transplantation
  • Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML, 2020, Leukemia
  • Conditioning intensity before allogeneic haematopoietic stem cell transplantation: a quality control audit, 2021, British Journal of Haematology

Frequent collaborators in the research of Alois Gratwohl include:

  • John A. Snowden
  • Rüdiger Hehlmann
  • Astghik Voskanyan
  • Michael Lauseker
  • Markus Pfirrmann

Alois Gratwohl's work has appeared repeatedly in several academic journals, with multiple publications in:

  • Leukemia
  • British Journal of Haematology
  • Cancer
  • Bone Marrow Transplantation
  • New England Journal of Medicine

Best Publications

  • Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

    Stephen G. O'Brien;François Guilhot;Richard A. Larson;Insa Gathmann

  • Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

    Brian J. Druker;François Guilhot;Stephen G. O'brien;Insa Gathmann

  • Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

    Hagop M Kantarjian;Charles Sawyers;Andreas Hochhaus;Francois Guilhot

  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Michele Baccarani;Giuseppe Saglio;John Goldman;Andreas Hochhaus

  • Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    Michele Baccarani;Jorge Cortes;Fabrizio Pane;Dietger Niederwieser

  • Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

    Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman

  • Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.

    Moshe Talpaz;Richard T. Silver;Brian J. Druker;John M. Goldman

  • High-dose daunorubicin in older patients with acute myeloid leukemia.

    Bob Löwenberg;Gert J. Ossenkoppele;Wim van Putten;Harry C. Schouten

  • Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation

    A. Gratwohl;J. Hermans;J. Goldman;W. Arcese

  • IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

    Rowlings Pa;Przepiorka D;Klein Jp;Gale Rp

  • Hematopoietic stem cell transplantation: a global perspective

    Alois Gratwohl;Helen Baldomero;Mahmoud Aljurf;Marcelo C. Pasquini

  • Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial

    J.M. van Laar;D. Farge;J.K. Sont;K. Naraghi

  • Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow Transplantation

    E.A.J.M. Goulmy;R. Schipper;J. Pool;E. Blokland

  • Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation

    Richard E. Champlin;Norbert Schmitz;Mary M. Horowitz;Bernard Chapuis

  • Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

    Jan J. Cornelissen;Wim L. J. van Putten;Leo F. Verdonck;Matthias Theobald

  • Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

    Mahmoud al-Jurf;Mahmoud al-Jurf;Francisco Aranha;Francisco Aranha;Claudio Annasetti;Jane F. Apperley;Jane F. Apperley

  • Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

    Bob Löwenberg;Wim van Putten;Matthias Theobald;Jurg Gmür

  • Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

    Enric Carreras;Hartmut Bertz;William Arcese;Jean-Paul Vernant

  • Cytarabine dose for acute myeloid leukemia.

    Bob Lowenberg;Thomas Pabst;Edo Vellenga;Wim van Putten

  • Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

    P. Ljungman;M. Bregni;M. Brune;J. Cornelissen

Frequent Co-Authors

André Tichelli
André Tichelli University Hospital of Basel
Jakob Passweg
Jakob Passweg University Hospital of Basel
Dietger Niederwieser
Dietger Niederwieser Leipzig University
Jane F. Apperley
Jane F. Apperley Imperial College London
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Hans-Jochem Kolb
Hans-Jochem Kolb Ludwig-Maximilians-Universität München
Rüdiger Hehlmann
Rüdiger Hehlmann Heidelberg University
Tapani Ruutu
Tapani Ruutu University of Helsinki
Vanderson Rocha
Vanderson Rocha Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always follow a single path—especially in today’s digital landscape. The growing availability of online degrees means more flexibility for those interested in healthcare roles, from administration to advanced practice nursing.

For students considering healthcare management, enrolling in one of the top cahme-accredited mha programs can open doors to leadership roles within hospitals and health systems. If you hold a nursing license and want to advance your education, you might explore rn bsn online programs no clinicals, which offer a streamlined way to earn a bachelor’s degree without additional clinical hours.

Nurses seeking the highest levels of practice have more efficient degree options, too. By enrolling in the shortest msn to dnp program, professionals can quickly transition to advanced, doctorate-level practice. Cost is another key concern for many; fortunately, there are institutions offering some of the cheapest dnp programs, making career advancement more accessible.

These flexible, accredited pathways help aspiring healthcare professionals build their expertise and shape rewarding careers across the medical field—all on their own schedule.

Best Scientists Citing Alois Gratwohl

Trending Scientists